Genetic Variation in CYP2D6 , UGT1A4 , SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron.

Autor:	Soria-Chacartegui, Paula1 (AUTHOR), Cendoya-Ramiro, Patricia1 (AUTHOR), González-Iglesias, Eva1 (AUTHOR), Martín-Vílchez, Samuel1 (AUTHOR), Rodríguez-Lopez, Andrea1 (AUTHOR), Mejía-Abril, Gina1 (AUTHOR), Román, Manuel1 (AUTHOR), Luquero-Bueno, Sergio1 (AUTHOR), Ochoa, Dolores1 (AUTHOR), Abad-Santos, Francisco1,2 (AUTHOR) francisco.abad@uam.es
Zdroj:	Pharmaceutics. Aug2024, Vol. 16 Issue 8, p1077. 14p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu